MOLECULAR GENETIC AND IMMUNOLOGICAL ASPECTS OF INVASIVE ASPERGILLOSIS
https://doi.org/10.22625/2072-6732-2017-9-1-47-54
Abstract
Aspergillus is very widely spread in nature. Daily people inhale to several thousand spores of micromycetes, however, an effective immune response prevents to development of the disease. In case of violation the mechanisms of innate and adaptive immune response as a result of genetic defects or iatrogenic immunosuppression Aspergillus spp. become pathogenic and can cause severe invasive infections in immunocompromised patients. Until now there are no reliable biomarkers for the risk prediction of invasive aspergillosis and monitoring the effectiveness of treatment of infectious process. In our review, we are considering the most important genetic and immunological factors affecting susceptibility to Aspergillus spp., The analysis of which can provide an individual approach to antifungal therapy / prevention in immunocompromised patients.
About the Authors
O. V. Shadrivova
North-Western State Medical University named after I.I. Mechnikov
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
E. V. Frolova
North-Western State Medical University named after I.I. Mechnikov
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
A. Е. Taraskina
North-Western State Medical University named after I.I. Mechnikov
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
N. N. Klimko
North-Western State Medical University named after I.I. Mechnikov
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
References
1. Klimko N., Kozlova Y., Khostelidi S., et al. The burden of serious fungal diseases in Russia // Mycoses, 2015, 58 (Suppl. S5), 58–62.
2. Pagano L., Caira M., Candoni A., et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study // Haematologica. 2010 Apr;95(4):644-50. doi: 10.3324/haematol.2009.012054.
3. Dragonetti G., Criscuolo M., Fianchi L., Pagano L. Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? // Med Mycol (2017) 55 (1): 8286. DOI: https://doi.org/10.1093/mmy/myw114
4. Klimko N.N., Shadrivova O.V., Khostelidi S.N. et al. Onkogematologiya. 2014; 2:13-19 (in Russian).
5. Segal BH. Aspergillosis. N Engl J Med 2009; 360:1870– 84.
6. Vinh DC, Sugui JA, Hsu AP, Freeman AF, Holland SM. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol 2010; 125:1389–90.
7. Caira M, Girmenia C, Fadda RM, et al. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk? Eur J Haematol 2008; 81:242–3.
8. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the TransplantAssociated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50:1091–100.
9. Neofytos D, Horn D, Anaissie E, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients:analysis of Multicenter Prospective Antifungal Therapy(PATH) Alliance registry. Clin Infect Dis 2009; 48:265–73.
10. Popova M.O., Zubarovskaya L.S., Klimko N.N. et al. Terapevticheskii arkhiv. 2012; 7:50-57 (in Russian).
11. Donnelly J. Peter A European period-prevalence study to estimate the rate of invasive pulmonary mould disease (PIMDA study) (Электронный ресурс) / J. Peter Donnelly // ECCMID. – online lecture library. – 2014. – P0028a. – Available from: https://www.escmid.org/.
12. Sterne JA, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysisof 18 HIV cohort studies. Lancet 2009; 373:1352–63.
13. Egli A, Humar A, Kumar D. State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician. Clin Infect Dis 2012; 55:1678–89.
14. Cunha C, Aversa F, Romani L, Carvalho A. Human genetic susceptibility to invasive aspergillosis. PLoS Pathog 2013; 9:e1003434.
15. Wojtowicz A, Bochud PY. Host genetics of invasive Aspergillus and Candida infections. Semin Immunopathol. 2015;37:173–86.
16. Oliveira-Coelho A, Rodrigues F, Campos A Jr, et al. Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis. Front Microbiol. 2015 May 5;6:411. doi: 10.3389/fmicb.2015.00411. eCollection 2015.
17. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11: 275-288.
18. Camargo JF, Husain S. Immune correlates of protection in human invasive aspergillosis. Clin Infect Dis 2014; 59: 569-77.
19. Moalli F, Doni A, Deban L, et al. Role of complement and Fcγ receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 2010; 116:5170–80.
20. Cunha C, Aversa F, Lacerda JF, et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med 2014; 370:421–32. DOI:16.3517.36.
21. Biagi E, Col M, Migliavacca M, et al. PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients. J Pediatr Hematol Oncol 2008; 30:881–5. DOI:10.1097/MPH.0b013e318180bc1d
22. Camargo Jose F., Bhimji A, Deepali Kumar, Rupert Kaul, Impaired T Cell Responsiveness to Interleukin-6 in Hematological Patients with Invasive Aspergillosis PLoS One. 2015 DOI:10.1371
23. Rivera A, Hohl TM, Collins N, et al. Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4T cell differentiation. J Exp Med 2011; 208:369–81
24. Werner JL, Metz AE, Horn D, et al. Requisite role for the dectin-1 beta glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009; 182:4938–46.
25. Cunha C, Di IM, Bozza S, et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipientand donor dependent mechanisms of antifungal immunity. Blood 2010; 116:5394–402.
26. Sainz J, Lupianez CB, Segura-Catena J, et al. Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary aspergillosis infection.PLoS One 2012; 7:e32273.
27. Bochud PY, Chien JW, Marr KA, et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med2008; 359:1766–77.
28. Fischer M, Spies-Weisshart B,Schrenk K, et al. Polymorphisms of Dectin-1 and TLR2 Predispose to Invasive Fungal Disease in Patients with Acute Myeloid Leukemia. PLoS One.2016 Mar 10;11(3):e0150632. doi: 10.1371/journal.pone.0150632. eCollection 2016.
29. Chamilos G, Ganguly D, Lande R, et al. Generation of IL23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of TH-17 responses. PLoS One 2010; 5:e12955.
30. Smith NL, Denning DW. Clinical implications of interferon-γ genetic and epigenetic variants.Immunology.2014 Dec;143(4):499-511. doi: 10.1111/imm.12362.
31. Lupianez CB, Canet LM, Carvalho A. Polymorphisms in host immunity modulating genes and risk of invasive aspergillosis: Results from the aspBIOmics consortium Infect Immun. 2015 Dec 14;84(3):643-57.
32. Stuehler C, Khanna N, Bozza S, et al. Cross protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 2011; 117: 5881-91.
33. Pelletier M., Maggi L., Micheletti A. et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010; 115:335–43.
34. Kim CJ, McKinnon LR, Kovacs C, et al. Mucosal Th17 cell function is altered during HIV infection and is an independent predictor of systemic immune activation. J Immunol 2013; 191:2164–73.
35. Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity. Blood 2013; 121:2402–14.
36. Carvalho A, Cunha C, Di IM, et al. Prognostic significance of genetic variantsin the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. Bone Marrow Transplant 2010;45:1645–52. doi: 10.1038/bmt.2010.28.
37. Milner JD, Brenchley JM, Laurence A, et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773–6.
38. Thakur R, Anand R, Tiwari S, et al. Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells? Frontiers in Microbiology | www.frontiersin.org May 2015 | Volume 6 | Article 429 P.1-6
39. Sainz J, Hassan L, Perez E, et al. Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis. Immunol Lett. 2007; 109:76–82. DOI:10.1016.2007.01.005
40. Hebart, H. Analysis of T cell responses to Aspergillus fumigates antigens in healthy individuals and patients with hematologic malignancies / H. Hebart, Bollinger, C. Fisch P., [et al.] // Blood. – 2002. – Vol. 100. – P.4521-4528.
41. Potenza L, Vallerini D, Barozzi P, et al. Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients. PLoS One 2013; 8(9): e74326.
42. Jolink H, Hagedoorn RS, Lagendijk EL, et al. Induction of A. fumigates specific CD4+ T cells in patients recovering from invasive aspergillosis. Haematologica 2014 Jul; 99(7): 1255–1263.
43. Stuehler C, Kuenzli E, Veronika K. Jaeger, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis. J Infect Dis. 2015 Sep 15;212(6):959-67
44. Frolovа E.V., Shadrivova O.V., Filippova L.V. et al. Problemy meditsinskoi mikologii. 2014; 16 (3): 37-44 (in Russian).
45. Shadrivova O.V., Frolovа E.V., Uchevatkina A.E. et al. Problemy meditsinskoi mikologii. 2015; 17(1):14-20. (in Russian).
46. Delsing CE, Becker KL, Simon A., et al. Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis. BMC Infect Dis. 2015 Mar 21;15:140. doi: 10.1186/s12879-015-0891-2
47. Khanna N, Stuehler C, Lunemann A., et al. Host response to fungal infections -how immunology and host genetics could help to identify and treat patients at risk. Swiss Med Wkly. 2016 Sep 21;146:w14350. doi: 10.4414/smw.2016.14350.
48. Kumaresan P.R., Manuri P.R., Albert N.D. et al. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection // PNAS. 2014. V. 111. № 29. P. 10660-10665. DOI: 10.1073/pnas.1312789111.
Review
For citations:
Shadrivova O.V., Frolova E.V., Taraskina A.Е., Klimko N.N. MOLECULAR GENETIC AND IMMUNOLOGICAL ASPECTS OF INVASIVE ASPERGILLOSIS. Journal Infectology. 2017;9(1):47-54. (In Russ.) https://doi.org/10.22625/2072-6732-2017-9-1-47-54
Views:
6127
.png)
.png)
Email this article 